Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Understanding Rare Conditions: Support & Connection

November 8, 2022

The internet has allowed people living with chronic conditions to find information, connection and support that might not have been readily available.

Socially Driven Insights Illuminate Real-Time Patient Needs

November 7, 2022

Survey data like Health Union's "In America" socially driven insights add more context and recency for understanding patient needs in real, actionable ways.

Understanding Rare Conditions: The Quest for Reliable Information

September 28, 2022

One-third of NMOSD In America respondents said they struggle to find reliable information on neuromyelitis optica spectrum disorder.

[GUIDE] Influencer Marketing and Social Health

September 2, 2022

This exclusive guide for pharma marketers details how to execute meaningful, scalable, and impactful influencer marketing campaigns with patient leaders.

Two phones are connected with a wire in the shape of a heart

Social Media Communities in Times of Physical Distance

August 20, 2020

While COVID-19 has resulted in a need to physically isolate, experts are concerned that the associated social isolation will have negative consequences.

Lung Cancer Patient-Reported Survey Data | 2020

August 13, 2020

Many people living with lung cancer report feeling a stigma associated with their condition, according to new Health Union survey data.

Patients play an active role in their treatment

Playing an Active Role in Treatment Yields More Confidence in Patients

August 4, 2020

Whether a person plays an active role in treatment or not, the majority of patients surveyed do not feel controlled on their current treatment plan.

Steroid Withdrawal Concerns in People with Atopic Dermatitis

July 30, 2020

More than half of people living with atopic dermatitis who have ever used topical corticosteroids say they are at least “somewhat concerned” about steroid withdrawal.

Healthcare Industry Thought Leadership

Contact